Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Sources of medical error in refractive surgery.

Moshirfar M, Simpson RG, Dave SB, Christiansen SM, Edmonds JN, Culbertson WW, Pascucci SE, Sher NA, Cano DB, Trattler WB.

J Refract Surg. 2013 May;29(5):303-10. doi: 10.3928/1081597X-20130415-01.

PMID:
23659228
2.

A retrospective review of photorefractive keratectomy to enhance earlier radial keratotomy.

Sher NA, Golben MP, Bond W, Trattler WB.

Int Ophthalmol Clin. 2011 Spring;51(2):39-49. doi: 10.1097/IIO.0b013e31820f88f0. No abstract available.

PMID:
21383578
3.

An in vitro evaluation of electromagnetic interference between implantable cardiac devices and ophthalmic laser systems.

Sher NA, Golben MP, Kresge K, Selznick L, Adabag S.

Europace. 2011 Apr;13(4):583-8. doi: 10.1093/europace/euq495. Epub 2011 Jan 19.

PMID:
21252191
4.

Topical bromfenac 0.09% vs. ketorolac 0.4% for the control of pain, photophobia, and discomfort following PRK.

Sher NA, Golben MR, Bond W, Trattler WB, Tauber S, Voirin TG.

J Refract Surg. 2009 Feb;25(2):214-20.

PMID:
19241773
5.

Hyperopic refractive surgery.

Sher NA.

Curr Opin Ophthalmol. 2001 Aug;12(4):304-8. Review.

PMID:
11507345
6.

The effect of various methods of eye immobilization on corneal topography.

Sher NA, Fundingsland BR, Bergin A, Burba T, Forber S, DeMarchi J.

J Refract Surg. 1996 May-Jun;12(4):467-71.

PMID:
8771542
7.

Results one year after using the 193-nm excimer laser for photorefractive keratectomy in mild to moderate myopia.

Talley AR, Hardten DR, Sher NA, Kim MS, Doughman DJ, Carpel E, Ostrov CS, Lane SS, Parker P, Lindstrom RL.

Am J Ophthalmol. 1994 Sep 15;118(3):304-11.

PMID:
8085586
8.

193-nm excimer photorefractive keratectomy in high myopia.

Sher NA, Hardten DR, Fundingsland B, DeMarchi J, Carpel E, Doughman DJ, Lane SS, Ostrov C, Eiferman R, Frantz JM, et al.

Ophthalmology. 1994 Sep;101(9):1575-82.

PMID:
8090459
9.

Role of topical corticosteroids and nonsteroidal antiinflammatory drugs in the etiology of stromal infiltrates after excimer photorefractive keratectomy.

Sher NA, Krueger RR, Teal P, Jans RG, Edmison D.

J Refract Corneal Surg. 1994 Sep-Oct;10(5):587-8. No abstract available.

PMID:
7530111
10.

Excimer photorefractive keratectomy in very high myopia.

Sher NA, Hardten DR, DeMarchi J, Lindstrom RL.

Semin Ophthalmol. 1994 Jun;9(2):97-101. Review. No abstract available.

PMID:
10147298
11.

Use of the 193 nm excimer laser for photorefractive keratectomy in low to moderate myopia.

Talley AR, Sher NA, Kim MS, Doughman DJ, Carpel E, Ostrov C, Lane SS, Parker P, Lindstrom RL.

J Cataract Refract Surg. 1994 Mar;20 Suppl:239-42.

PMID:
8006794
12.

Topical diclofenac in the treatment of ocular pain after excimer photorefractive keratectomy.

Sher NA, Frantz JM, Talley A, Parker P, Lane SS, Ostrov C, Carpel E, Doughman D, DeMarchi J, Lindstrom R.

Refract Corneal Surg. 1993 Nov-Dec;9(6):425-36.

PMID:
8117641
13.

Topical diclofenac reduces pain following photorefractive keratectomy.

Eiferman RA, Hoffman RS, Sher NA.

Arch Ophthalmol. 1993 Aug;111(8):1022. No abstract available.

PMID:
8352677
14.

Excimer laser photorefractive keratectomy in high myopia. A multicenter study.

Sher NA, Barak M, Daya S, DeMarchi J, Tucci A, Hardten DR, Frantz JM, Eiferman RA, Parker P, Telfair WB 3rd, et al.

Arch Ophthalmol. 1992 Jul;110(7):935-43.

PMID:
1637278
15.

Excimer laser photorefractive keratectomy in high myopia: a multicenter study.

Lindstrom RL, Sher NA, Barak M, DeMarchi J, Tucci A, Daya S, Hardten DR, Frantz JM, Eifermn RA, Parker P, et al.

Trans Am Ophthalmol Soc. 1992;90:277-96; discussion 296-301. No abstract available.

16.

The use of the 193-nm excimer laser for myopic photorefractive keratectomy in sighted eyes. A multicenter study.

Sher NA, Chen V, Bowers RA, Frantz JM, Brown DC, Eiferman R, Lane SS, Parker P, Ostrov C, Doughman D, et al.

Arch Ophthalmol. 1991 Nov;109(11):1525-30.

PMID:
1755731
17.

Clinical use of the 193-nm excimer laser in the treatment of corneal scars.

Sher NA, Bowers RA, Zabel RW, Frantz JM, Eiferman RA, Brown DC, Rowsey JJ, Parker P, Chen V, Lindstrom RL.

Arch Ophthalmol. 1991 Apr;109(4):491-8.

PMID:
2012547
18.

Use of the 193-NM excimer laser for myopic photorefractive keratectomy in sighted eyes: a multicenter study.

Lindstrom RL, Sher NA, Chen V, Bowers RA, Frantz JM, Brown DC, Eiferman R, Lane SS, Parker P, Ostrov C, et al.

Trans Am Ophthalmol Soc. 1991;89:155-72; discussion 172-82. No abstract available.

19.

Myopic excimer laser keratectomy: a preliminary report.

Zabel RW, Sher NA, Ostrov CS, Parker P, Lindstrom RL.

Refract Corneal Surg. 1990 Sep-Oct;6(5):329-34.

PMID:
2257256
20.

Clinical signs and medical therapy of early Acanthamoeba keratitis.

Lindquist TD, Sher NA, Doughman DJ.

Arch Ophthalmol. 1988 Jan;106(1):73-7.

PMID:
3337710
21.

Unilateral papilledema in 'benign' intracranial hypertension (pseudotumor cerebri).

Sher NA, Wirtschafter J, Shapiro SK, See C, Shapiro I.

JAMA. 1983 Nov 4;250(17):2346-7.

PMID:
6632132
22.

The ocular manifestations in Fabry's disease.

Sher NA, Letson RD, Desnick RJ.

Arch Ophthalmol. 1979 Apr;97(4):671-6.

PMID:
106811
23.

Central retinal artery occlusion complicating Fabry's disease.

Sher NA, Reiff W, Letson RD, Desnick RJ.

Arch Ophthalmol. 1978 May;96(5):815-7.

PMID:
207248
24.

Bilateral intraocular Nocardia asteroides infection.

Sher NA, Hill CW, Eifrig DE.

Arch Ophthalmol. 1977 Aug;95(8):1415-8.

PMID:
329816
25.

Effect of Corynebacterium parvum, methanol-extraction residue of BCG, and levamisole on macrophage random migration, chemotaxis, and pinocytosis.

Sher NA, Poplack DG, Blaese RM, Brown TM, Chaparas SD.

J Natl Cancer Inst. 1977 Jun;58(6):1753-7.

PMID:
864753
26.
27.

Contrasting effects of BCG on spleen and lymph node antibody responses in nude and normal mice.

Doft BH, Merchant B, Johannessen L, Chaparas SD, Sher NA.

J Immunol. 1976 Nov;117(5 Pt 1):1638-43.

PMID:
1087322
28.
29.
31.

Response of congenitally athymic (nude) mice to infection with Mycobacterium bovis (strain BCG).

Sher NA, Chaparas SD, Greenberg LE, Merchant EB, Vickers JH.

J Natl Cancer Inst. 1975 Jun;54(6):1419-26.

PMID:
1094126
32.

Combined drug and immunostimulation therapy against a syngeneic murine leukemia.

Pearson JW, Chirigos MA, Chaparas SD, Sher NA.

J Natl Cancer Inst. 1974 Feb;52(2):463-8. No abstract available.

PMID:
4593139
33.

The effect of drug therapy against a histologically defined rat leukemia.

Pearson JW, Chaparas SD, Torgersen JA, Perk K, Chirigos MA, Sher NA.

Cancer Res. 1974 Feb;34(2):355-61. No abstract available.

34.

Effect of three strains of BCG against a murine leukemia after drug therapy.

Sher NA, Pearson JW, Chaparas SD, Chirigos MA.

J Natl Cancer Inst. 1973 Dec;51(6):2001-3. No abstract available.

PMID:
4587756
35.

Virulence of six strains of Mycobacterium bovis (BCG) in mice.

Sher NA, Chaparas SD, Pearson J, Chirigos M.

Infect Immun. 1973 Nov;8(5):736-42.

Supplemental Content

Support Center